research
CONTRAST-ENHANCED ULTRASOUND MONITORING OF PERFUSION CHANGES IN HEPATIC NEUROENDOCRINE METASTASES AFTER SYSTEMIC VERSUS SELECTIVE ARTERIAL 177LU/90Y-DOTATOC AND 213BI-DOTATOC RADIOPEPTIDE THERAPY
- Publication date
- 11 June 2013
- Publisher
- MORION LLC, 10A Bazhana ave., 02140, Kyiv-140, Ukraine